HK1204016A1 - Methods and kits for detecting subjects at risk of having cancer - Google Patents

Methods and kits for detecting subjects at risk of having cancer

Info

Publication number
HK1204016A1
HK1204016A1 HK15104496.4A HK15104496A HK1204016A1 HK 1204016 A1 HK1204016 A1 HK 1204016A1 HK 15104496 A HK15104496 A HK 15104496A HK 1204016 A1 HK1204016 A1 HK 1204016A1
Authority
HK
Hong Kong
Prior art keywords
kits
cancer
risk
methods
detecting subjects
Prior art date
Application number
HK15104496.4A
Other languages
English (en)
Chinese (zh)
Inventor
Ganepola A P Ganepola
Original Assignee
Valley Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valley Health System filed Critical Valley Health System
Publication of HK1204016A1 publication Critical patent/HK1204016A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK15104496.4A 2011-12-19 2015-05-12 Methods and kits for detecting subjects at risk of having cancer HK1204016A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161577441P 2011-12-19 2011-12-19
PCT/US2012/068148 WO2013095941A1 (en) 2011-12-19 2012-12-06 Methods and kits for detecting subjects at risk of having cancer

Publications (1)

Publication Number Publication Date
HK1204016A1 true HK1204016A1 (en) 2015-11-06

Family

ID=48669353

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104496.4A HK1204016A1 (en) 2011-12-19 2015-05-12 Methods and kits for detecting subjects at risk of having cancer

Country Status (6)

Country Link
US (2) US9850541B2 (xx)
EP (1) EP2800820B1 (xx)
JP (2) JP6408380B2 (xx)
CA (1) CA2859021A1 (xx)
HK (1) HK1204016A1 (xx)
WO (1) WO2013095941A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447471B2 (en) * 2011-12-29 2016-09-20 Quest Diagnostics Investments Incorporated Microrna profiling for diagnosis of dysplastic nevi and melanoma
US9377091B2 (en) * 2013-06-21 2016-06-28 Eaton Corporation Shaft assemblies suitable for circuit breakers and related circuit breakers
EP2829613A1 (en) * 2013-07-26 2015-01-28 Istituto Nazionale Di Genetica Molecolare-INGM Biomarkers of liver diseases and uses thereof
WO2015073531A1 (en) * 2013-11-13 2015-05-21 The Texas A & M University System Micro-rnas that modulate lymphangiogenesis and inflammatory pathways in lymphatic vessel cells
JP6611411B2 (ja) * 2013-12-05 2019-11-27 東レ株式会社 膵臓がんの検出キット及び検出方法
CN106459961B (zh) * 2014-05-30 2020-08-25 东丽株式会社 胰腺癌的检测试剂盒或装置以及检测方法
EP3971299A3 (en) 2014-06-13 2022-06-29 Toray Industries, Inc. Colorectal cancer detection kit or device, and detection method
JP5852759B1 (ja) * 2015-04-01 2016-02-03 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
JP5970123B1 (ja) * 2015-12-04 2016-08-17 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
EP3988668A3 (en) 2016-03-31 2022-06-29 Toray Industries, Inc. Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor
JP2020513574A (ja) * 2016-11-24 2020-05-14 ヒュベット バイオ, インコーポレイテッドHuvet Bio, Inc. 疾患の診断用組成物
EP3725881A1 (en) * 2017-12-13 2020-10-21 Hiroshima University Method for aiding detection of pancreatic cancer
EP3725897A4 (en) 2017-12-13 2022-01-05 Hiroshima University HEAD AND NECK CANCER CANCER ASSISTANCE PROCESS
WO2021118349A1 (en) * 2019-12-10 2021-06-17 Prinses Máxima Centrum Voor Kinderoncologie B.V. Methods of typing germ cell tumors

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5215882A (en) 1989-11-30 1993-06-01 Ortho Diagnostic Systems, Inc. Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5707807A (en) 1995-03-28 1998-01-13 Research Development Corporation Of Japan Molecular indexing for expressed gene analysis
US5958342A (en) 1996-05-17 1999-09-28 Incyte Pharmaceuticals, Inc. Jet droplet device
US6060240A (en) 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
US6090556A (en) 1997-04-07 2000-07-18 Japan Science & Technology Corporation Method for quantitatively determining the expression of a gene
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US6004755A (en) 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US6048695A (en) 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
DE60332948D1 (de) 2002-07-19 2010-07-22 Althea Technologies Inc Strategien zur genexpressionsanalyse
US20060094025A1 (en) * 2004-11-02 2006-05-04 Getts Robert C Methods for detection of microrna molecules
EP2487260B1 (en) * 2006-01-05 2015-07-08 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis and treatment of solid cancers
EP2522747A1 (en) 2006-03-02 2012-11-14 The Ohio State University MicroRNA expression profile associated with pancreatic cancer
WO2008124777A1 (en) * 2007-04-10 2008-10-16 National Taiwan University Predicting post-treatment survival in cancer patients with micrornas
WO2008154333A2 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. Mir-34 regulated genes and pathways as targets for therapeutic intervention
EP2340310B1 (en) * 2008-09-22 2015-06-03 RXi Pharmaceuticals Corporation Reduced size self-delivering rnai compounds
WO2010048317A2 (en) 2008-10-21 2010-04-29 The Board Of Regents Of The University Of Texas System Micro-rnas as markers for tumor progression
US8735074B2 (en) 2009-08-28 2014-05-27 Asuragen, Inc. MiRNA biomarkers of lung disease
EP3150721B1 (en) * 2009-12-24 2019-05-15 Micromedmark Biotech Co., Ltd Pancreatic cancer markers and detecting methods
US20130065778A1 (en) * 2010-01-26 2013-03-14 Yale University MicroRNA Signatures Predicting Responsiveness To Anti-HER2 Therapy
US20110223607A1 (en) 2010-03-12 2011-09-15 Quest Diagnostics Investments Incorporated Circulating microrna as a marker for hepatocellular carcinoma

Also Published As

Publication number Publication date
JP2015502176A (ja) 2015-01-22
US9850541B2 (en) 2017-12-26
JP2019030305A (ja) 2019-02-28
WO2013095941A1 (en) 2013-06-27
US20150011410A1 (en) 2015-01-08
EP2800820A4 (en) 2016-03-30
CA2859021A1 (en) 2013-06-27
US20180105888A1 (en) 2018-04-19
EP2800820B1 (en) 2020-04-08
JP6720260B2 (ja) 2020-07-08
EP2800820A1 (en) 2014-11-12
JP6408380B2 (ja) 2018-10-17

Similar Documents

Publication Publication Date Title
HK1204016A1 (en) Methods and kits for detecting subjects at risk of having cancer
HK1206065A1 (en) Compositions and methods for analyte detection
HK1212932A1 (zh) 用於檢測和獲取生物標誌物的方法和裝置
HK1209793A1 (en) Methods of detecting diseases or conditions
EP2847593A4 (en) METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER
GB2507231B (en) Methods for Detection of Cytosine Modification
EP2670866A4 (en) BIOMARKERS AND METHODS OF USE
EP2790579A4 (en) METHOD AND APPARATUS FOR DETECTING THE APPEARANCE OF HYPOGLYCEMIA
HK1200037A1 (en) Non-invasive methods of detecting target molecules
HK1198705A1 (en) Apparatus and methods for detecting analytes
EP2675485A4 (en) ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER
HK1259001A1 (zh) 癌症的預後和診斷方法
EP2668295A4 (en) METHODS OF DETECTING LUNG CANCER
GB201120965D0 (en) System and method for detection of analytes
GB2533873B (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
IL232493A0 (en) A method for quantifying cancer treatment
IL230693A0 (en) Use of the i-3859 antibody for the detection and diagnosis of cancer
IL236436A0 (en) Kits and methods for the detection of cyanide
HK1205558A1 (en) Methods and biomarkers for detection and prognosis of cervical cancer
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
EP2904393A4 (en) METHOD AND KIT FOR MEASURING AN ANALYTE UNDER ACIDIC CONDITIONS
GB201215924D0 (en) Kit and method for quantitative detection of steroids
EP2894474A4 (en) METHOD AND KIT FOR DETECTION OF RENAL CANCER BIOMARKERS IN THE BLOOD
EP2786150A4 (en) DETECTION OF MULTIPLE ANALYTES
EP2699699A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER